Anlon Healthcare Limited has executed share swap agreements to acquire up to 32.52% in Apiqo Organics & up to 43.33% in Bizotic Lifescience. This move aims to strengthen supply chains, create synergies, and boost shareholder value. The total consideration involves issuing approximately 8.59 Cr equity shares.
Anlon Healthcare's CMD discussed business performance, industry outlook, operational updates, growth strategy, and capital expenditure in a Money TV interview. No UPSI was shared.
ANLON HEALTHCARE: MD to feature on NDTV Profit's "Small Cap Buzzers" to discuss growth, recent developments, and future outlook, based on public information.
ANLON HEALTHCARE CMD discussed FY25-26 financial performance, business developments, and industry outlook in a media interview. No unpublished price-sensitive information was disclosed.
Anlon Healthcare has received new ISINs for its sub-divided equity shares. The split, from face value Rs. 10 to Rs. 2, is effective, with depositories NSDL and CDSL confirming the activation.
